Age and diet act through distinct isoforms of the class II transactivator gene in mouse intestinal epithelium

Gastroenterology

Volumn 127, Issue 1, 2004, Pages 203-212

  Sanderson, Ian R ^a,b,c   Bustin, Stephen A ^a   Dziennis, Suzan ^b   Paraszczuk, Joanna ^a   Stamm, Demetra S ^a,b  

^a Instituteof Cell and Molecular Science   (United Kingdom)

^b Harvard Clinical Nutrition Research Center   (United States)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

IEC; IFN; interferon; intestinal epithelial cells; major histocompatibility complex; MHC; PCR; polymerase chain reaction; ribonuclease; RNase

Indexed keywords

EDETIC ACID; GAMMA INTERFERON RECEPTOR; ISOPROTEIN; MESSENGER RNA; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL TYPE; CONTROLLED STUDY; DIET; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; RNA EXTRACTION; WEANING; WILD TYPE;

EID: 3242727954     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.04.014     Document Type: Article

References (42)

1. Unanue E.R., Beller D.I., Lu C.Y., Allen P.M. Antigen presentation comments on its regulation and mechanism. J Immunol. 132:1984;1-5
2. Stockinger B., Pessara U., Lin R.H., Habicht J., Grez M., Koch N. A role of Ia-associated invariant chains in antigen processing and presentation. Cell. 56:1989;683-689
3. Bland P.W., Warren L.G. Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-Ia antisera. Immunology. 58:1986;1-7
4. Kaiserlian D., Vidal K., Revillard J.P. Murine enterocytes can present soluble antigen to specific class II- restricted CD4+ T cells. Eur J Immunol. 19:1989;1513-1516
5. Mayer L., Shlien R. Evidence for function of Ia molecules on gut epithelial cells in man. J Exp Med. 166:1987;1471-1483
6. Hershberg R.M., Framson P.E., Cho D.H., Lee L.Y., Kovats S., Beitz J., Blum J.S., Nepom G.T. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J Clin Invest. 100:1997;204-215
7. Hershberg R.M., Cho D.H., Youakim A., Bradley M.B., Lee J.S., Framson P.E., Nepom G.T. Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells. J Clin Invest. 102:1998;792-803
8. Sanderson I.R., Ouellette A.J., Carter E.A., Harmatz P.R. Ontogeny of class II MHC mRNA in the mouse small intestinal epithelium. Mol Immunol. 29:1992;1257-1263
9. Framson P.E., Cho D.H., Lee L.Y., Hershberg R.M. Polarized expression and function of the costimulatory molecule CD58 on human intestinal epithelial cells. Gastroenterology. 116:1999;1054-1062
10. Kvale D., Krajci P., Brandtzaeg P. Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines. Scand J Immunol. 35:1992;669-676
11. Sanderson I.R., Ouellette A.J., Carter E.A., Walker W.A., Harmatz P.R. Differential regulation of B7 mRNA in enterocytes and lymphoid cells. Immunology. 79:1993;434-438
12. Campbell N., Yio X.Y., So L.P., Li Y., Mayer L. The intestinal epithelial cell processing and presentation of antigen to the mucosal immune system. Immunol Rev. 172:1999;315-324
13. van Niel G., Raposo G., Candalh C., Boussac M., Hershberg R., Cerf-Bensussan N., Heyman M. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology. 121:2001;337-349
14. Steimle V., Otten L.A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 75:1993;135-146
15. Waldburger J.M., Masternak K., Muhlethaler-Mottet A., Villard J., Peretti M., Landmann S., Reith W. Lessons from the bare lymphocyte syndrome molecular mechanisms regulating MHC class II expression. Immunol Rev. 178:2000;148-165
16. Elhasid R., Etzioni A. Major histocompatibility complex class II deficiency a clinical review. Blood Rev. 10:1996;242-248
17. Klein C., Lisowska-Grospierre B., LeDeist F., Fischer A., Griscelli C. Major histocompatibility complex class II deficiency clinical manifestations, immunologic features, and outcome. J Pediatr. 123:1993;921-928
18. Masternak K., Muhlethaler-Mottet A., Villard J., Zufferey M., Steimle V., Reith W. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14:2000;1156-1166
19. Muhlethaler-Mottet A., Otten L.A., Steimle V., Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:1997;2851-2860
20. Nikcevich K.M., Piskurich J.F., Hellendall R.P., Wang Y., Ting J.P. Differential selectivity of CIITA promoter activation by IFN-γ and IRF-1 in astrocytes and macrophages CIITA promoter activation is not affected by TNF-α J Neuroimmunol. 99:1999;195-204
21. Muhlethaler-Mottet A., Di Berardino W., Otten L.A., Mach B. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1. Immunity. 8:1998;157-166
22. Dong Y., Rohn W.M., Benveniste E.N. IFN-γ regulation of the type IV class II transactivator promoter in astrocytes. J Immunol. 162:1999;4731-4739
23. Piskurich J.F., Linhoff M.W., Wang Y., Ting J.P. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta. Mol Cell Biol. 19:1999;431-440
24. Mayrhofer G., Pugh C.W., Barclay A.N. The distribution, ontogeny and origin in the rat of Ia-positive cells with dendritic morphology and of Ia antigen in epithelia, with special reference to the intestine. Eur J Immunol. 13:1983;112-122
25. Hughes A., Bloch K.J., Bhan A.K., Gillen D., Giovino V.C., Harmatz P.R. Expression of MHC class II (Ia) antigen by the neonatal enterocyte the effect of treatment with interferon-γ Immunology. 72:1991;491-496
26. Sanderson I.R., Ouellette A.J., Carter E.A., Harmatz P.R. Ontogeny of Ia messenger RNA in the mouse small intestinal epithelium is modulated by age of weaning and diet. Gastroenterology. 105:1993;974-980
27. Janitz M., Reiners-Schramm L., Muhlethaler-Mottet A., Rosowski M., Lauster R. Analysis of the sequence polymorphism within Class II transactivator gene promoters. Exp Clin Immunogenet. 18:2001;199-205
28. Bjerknes M., Cheng H. Methods for the isolation of intact epithelium from the mouse intestine. Anat Rec. 199:1981;565-574
29. Ouellette A.J., Frederick D., Hagen S.J., Katz J.D. Class II antigen-associated invariant chain mRNA in mouse small intestine. Biochem Biophys Res Commun. 179:1991;1642-1648
30. Ouellette A.J., Greco R.M., James M., Frederick D., Naftilan J., Fallon J.T. Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium. J Cell Biol. 108:1989;1687-1695
31. Ouellette A.J., Cordell B. Accumulation of abundant messenger ribonucleic acids during postnatal development of mouse small intestine. Gastroenterology. 94:1988;114-121
32. Enoch T., Zinn K., Maniatis T. Activation of the human β-interferon gene requires an interferon- inducible factor. Mol Cell Biol. 6:1986;801-810
33. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 25:2000;169-193
34. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 265:1994;106-109
35. Chang C.H., Hong S.C., Hughes C.C., Janeway C.A. Jr, Flavell R.A. CIITA activates the expression of MHC class II genes in mouse T cells. Int Immunol. 7:1995;1515-1518
36. Chin K.C., Mao C., Skinner C., Riley J.L., Wright K.L., Moreno C.S., Stark G.R., Boss J.M., Ting J.P. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity. 1:1994;687-697
37. Bregenholt S., Brimnes J., Nissen M.H., Claesson M.H. In vitro activated CD4+ T cells from interferon-γ (IFN-γ)- deficient mice induce intestinal inflammation in immunodeficient hosts. Clin Exp Immunol. 118:1999;228-234
38. Matsumoto S., Setoyama H., Umesaki Y. Differential induction of major histocompatibility complex molecules on mouse intestine by bacterial colonization. Gastroenterology. 103:1992;1777-1782
39. Axelsson C.K., Justesen T. Studies of the duodenal and fecal flora in gastrointestinal disorders during treatment with an elemental diet. Gastroenterology. 72:1977;397-401
40. Stanford J.R., Ayers L.W., Cornhill J.F., Carey L.C., Kilman J.W., Pace W.G., Vasko J.S. Alterations in gastrointestinal contents induced by elemental diets. J Surg Oncol. 12:1979;165-167
41. Siavoshian S., Blottiere H.M., Bentouimou N., Cherbut C., Galmiche J.P. Butyrate enhances major histocompatibility complex class I, HLA-DR, and ICAM-1 antigen expression on differentiated human intestinal epithelial cells. Eur J Clin Invest. 26:1996;803-810
42. Sanderson I.R., Boulton P., Menzies I., Walker-Smith J.A. Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet. Gut. 28:1987;1073-1076